nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Speech impairment NOS—Fluorouracil—head and neck cancer	0.0925	0.0925	CcSEcCtD
Nalbuphine—Numbness—Vinblastine—head and neck cancer	0.0371	0.0371	CcSEcCtD
Nalbuphine—Sensory loss—Vinblastine—head and neck cancer	0.0355	0.0355	CcSEcCtD
Nalbuphine—Tingling sensation—Fluorouracil—head and neck cancer	0.0251	0.0251	CcSEcCtD
Nalbuphine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.025	0.025	CcSEcCtD
Nalbuphine—Numbness—Fluorouracil—head and neck cancer	0.0244	0.0244	CcSEcCtD
Nalbuphine—Speech disorder—Fluorouracil—head and neck cancer	0.0235	0.0235	CcSEcCtD
Nalbuphine—Sensory loss—Fluorouracil—head and neck cancer	0.0233	0.0233	CcSEcCtD
Nalbuphine—Redness—Docetaxel—head and neck cancer	0.0216	0.0216	CcSEcCtD
Nalbuphine—Euphoric mood—Fluorouracil—head and neck cancer	0.0174	0.0174	CcSEcCtD
Nalbuphine—Depression—Vinblastine—head and neck cancer	0.0172	0.0172	CcSEcCtD
Nalbuphine—Swelling—Fluorouracil—head and neck cancer	0.0166	0.0166	CcSEcCtD
Nalbuphine—Hypoaesthesia—Vinblastine—head and neck cancer	0.0154	0.0154	CcSEcCtD
Nalbuphine—Injection site reaction—Docetaxel—head and neck cancer	0.0145	0.0145	CcSEcCtD
Nalbuphine—Hallucination—Hydroxyurea—head and neck cancer	0.014	0.014	CcSEcCtD
Nalbuphine—Cardiac arrest—Fluorouracil—head and neck cancer	0.0139	0.0139	CcSEcCtD
Nalbuphine—Pulmonary oedema—Docetaxel—head and neck cancer	0.013	0.013	CcSEcCtD
Nalbuphine—Erythema—Hydroxyurea—head and neck cancer	0.0123	0.0123	CcSEcCtD
Nalbuphine—Vertigo—Vinblastine—head and neck cancer	0.0121	0.0121	CcSEcCtD
Nalbuphine—Swelling—Docetaxel—head and neck cancer	0.012	0.012	CcSEcCtD
Nalbuphine—Convulsion—Vinblastine—head and neck cancer	0.0117	0.0117	CcSEcCtD
Nalbuphine—Hypertension—Vinblastine—head and neck cancer	0.0116	0.0116	CcSEcCtD
Nalbuphine—Convulsion—Hydroxyurea—head and neck cancer	0.0106	0.0106	CcSEcCtD
Nalbuphine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0101	0.0101	CcSEcCtD
Nalbuphine—Oedema—Hydroxyurea—head and neck cancer	0.01	0.01	CcSEcCtD
Nalbuphine—Paraesthesia—Vinblastine—head and neck cancer	0.00986	0.00986	CcSEcCtD
Nalbuphine—Cramp muscle—Docetaxel—head and neck cancer	0.00953	0.00953	CcSEcCtD
Nalbuphine—Feeling abnormal—Vinblastine—head and neck cancer	0.00905	0.00905	CcSEcCtD
Nalbuphine—Bronchospasm—Docetaxel—head and neck cancer	0.009	0.009	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00898	0.00898	CcSEcCtD
Nalbuphine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00893	0.00893	CcSEcCtD
Nalbuphine—Somnolence—Hydroxyurea—head and neck cancer	0.0089	0.0089	CcSEcCtD
Nalbuphine—Erythema—Fluorouracil—head and neck cancer	0.00883	0.00883	CcSEcCtD
Nalbuphine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00881	0.00881	CcSEcCtD
Nalbuphine—Abdominal pain—Vinblastine—head and neck cancer	0.00868	0.00868	CcSEcCtD
Nalbuphine—Vision blurred—Fluorouracil—head and neck cancer	0.00832	0.00832	CcSEcCtD
Nalbuphine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00825	0.00825	CcSEcCtD
Nalbuphine—Hypersensitivity—Vinblastine—head and neck cancer	0.00809	0.00809	CcSEcCtD
Nalbuphine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00791	0.00791	CcSEcCtD
Nalbuphine—Asthenia—Vinblastine—head and neck cancer	0.00788	0.00788	CcSEcCtD
Nalbuphine—Convulsion—Fluorouracil—head and neck cancer	0.00765	0.00765	CcSEcCtD
Nalbuphine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00738	0.00738	CcSEcCtD
Nalbuphine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00728	0.00728	CcSEcCtD
Nalbuphine—Confusional state—Fluorouracil—head and neck cancer	0.00727	0.00727	CcSEcCtD
Nalbuphine—Dizziness—Vinblastine—head and neck cancer	0.00726	0.00726	CcSEcCtD
Nalbuphine—Oedema—Fluorouracil—head and neck cancer	0.00721	0.00721	CcSEcCtD
Nalbuphine—Asthenia—Hydroxyurea—head and neck cancer	0.00718	0.00718	CcSEcCtD
Nalbuphine—Tachycardia—Fluorouracil—head and neck cancer	0.00703	0.00703	CcSEcCtD
Nalbuphine—Vomiting—Vinblastine—head and neck cancer	0.00698	0.00698	CcSEcCtD
Nalbuphine—Headache—Vinblastine—head and neck cancer	0.00688	0.00688	CcSEcCtD
Nalbuphine—Flushing—Docetaxel—head and neck cancer	0.00679	0.00679	CcSEcCtD
Nalbuphine—Hypotension—Fluorouracil—head and neck cancer	0.00673	0.00673	CcSEcCtD
Nalbuphine—Dizziness—Hydroxyurea—head and neck cancer	0.00662	0.00662	CcSEcCtD
Nalbuphine—Nausea—Vinblastine—head and neck cancer	0.00652	0.00652	CcSEcCtD
Nalbuphine—Paraesthesia—Fluorouracil—head and neck cancer	0.00647	0.00647	CcSEcCtD
Nalbuphine—Dyspnoea—Fluorouracil—head and neck cancer	0.00643	0.00643	CcSEcCtD
Nalbuphine—Somnolence—Fluorouracil—head and neck cancer	0.00641	0.00641	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—head and neck cancer	0.00637	0.00637	CcSEcCtD
Nalbuphine—Vomiting—Hydroxyurea—head and neck cancer	0.00637	0.00637	CcSEcCtD
Nalbuphine—Dyspepsia—Fluorouracil—head and neck cancer	0.00634	0.00634	CcSEcCtD
Nalbuphine—Rash—Hydroxyurea—head and neck cancer	0.00631	0.00631	CcSEcCtD
Nalbuphine—Dermatitis—Hydroxyurea—head and neck cancer	0.00631	0.00631	CcSEcCtD
Nalbuphine—Headache—Hydroxyurea—head and neck cancer	0.00627	0.00627	CcSEcCtD
Nalbuphine—Dysgeusia—Docetaxel—head and neck cancer	0.00624	0.00624	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—head and neck cancer	0.00613	0.00613	CcSEcCtD
Nalbuphine—Nausea—Hydroxyurea—head and neck cancer	0.00595	0.00595	CcSEcCtD
Nalbuphine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00594	0.00594	CcSEcCtD
Nalbuphine—Urticaria—Fluorouracil—head and neck cancer	0.00573	0.00573	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—head and neck cancer	0.00572	0.00572	CcSEcCtD
Nalbuphine—Body temperature increased—Fluorouracil—head and neck cancer	0.0057	0.0057	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—head and neck cancer	0.0056	0.0056	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—head and neck cancer	0.00552	0.00552	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—head and neck cancer	0.0055	0.0055	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00531	0.00531	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—head and neck cancer	0.00531	0.00531	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—head and neck cancer	0.00524	0.00524	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—head and neck cancer	0.0052	0.0052	CcSEcCtD
Nalbuphine—Shock—Docetaxel—head and neck cancer	0.00512	0.00512	CcSEcCtD
Nalbuphine—Pruritus—Fluorouracil—head and neck cancer	0.0051	0.0051	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—head and neck cancer	0.00508	0.00508	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—head and neck cancer	0.00486	0.00486	CcSEcCtD
Nalbuphine—Dizziness—Fluorouracil—head and neck cancer	0.00477	0.00477	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—head and neck cancer	0.00467	0.00467	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—head and neck cancer	0.00464	0.00464	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—head and neck cancer	0.00462	0.00462	CcSEcCtD
Nalbuphine—Vomiting—Fluorouracil—head and neck cancer	0.00458	0.00458	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—head and neck cancer	0.00458	0.00458	CcSEcCtD
Nalbuphine—Rash—Fluorouracil—head and neck cancer	0.00454	0.00454	CcSEcCtD
Nalbuphine—Dermatitis—Fluorouracil—head and neck cancer	0.00454	0.00454	CcSEcCtD
Nalbuphine—Headache—Fluorouracil—head and neck cancer	0.00451	0.00451	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—head and neck cancer	0.00429	0.00429	CcSEcCtD
Nalbuphine—Nausea—Fluorouracil—head and neck cancer	0.00428	0.00428	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00425	0.00425	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—head and neck cancer	0.00383	0.00383	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—head and neck cancer	0.00373	0.00373	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—head and neck cancer	0.00368	0.00368	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—head and neck cancer	0.00344	0.00344	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—head and neck cancer	0.00331	0.00331	CcSEcCtD
Nalbuphine—Rash—Docetaxel—head and neck cancer	0.00328	0.00328	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—head and neck cancer	0.00328	0.00328	CcSEcCtD
Nalbuphine—Headache—Docetaxel—head and neck cancer	0.00326	0.00326	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—head and neck cancer	0.00309	0.00309	CcSEcCtD
